RemeGen Co Ltd
HKEX:9995
RemeGen Co Ltd
Cash from Investing Activities
RemeGen Co Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
RemeGen Co Ltd
HKEX:9995
|
Cash from Investing Activities
-¥816.7m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-60%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Cash from Investing Activities
¥117.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash from Investing Activities
-¥1.1B
|
CAGR 3-Years
41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash from Investing Activities
-¥2.1B
|
CAGR 3-Years
-91%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash from Investing Activities
-¥942.6m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-14%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Cash from Investing Activities
-¥943.7m
|
CAGR 3-Years
-233%
|
CAGR 5-Years
-143%
|
CAGR 10-Years
N/A
|
See Also
What is RemeGen Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-816.7m
CNY
Based on the financial report for Dec 31, 2023, RemeGen Co Ltd's Cash from Investing Activities amounts to -816.7m CNY.
What is RemeGen Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-60%
Over the last year, the Cash from Investing Activities growth was 4%. The average annual Cash from Investing Activities growth rates for RemeGen Co Ltd have been -19% over the past three years , -60% over the past five years .